Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

Why Factorial Energy Stock Is Falling After Stellantis Battery Milestone

by Akanksha Bakshi | Jun 11, 2026 | General

Shares of Factorial Energy Inc. (NASDAQ:FAC), a solid-state battery developer, traded lower on Thursday, underperforming the broader market. • Factorial Energy shares are sliding. Why is FAC stock dropping? Stellantis Battery Integration The decline followed news that...

Why Factorial Energy Stock Is Falling After Stellantis Battery Milestone

by Akanksha Bakshi | Jun 11, 2026 | General

Shares of Factorial Energy Inc. (NASDAQ:FAC), a solid-state battery developer, traded lower on Thursday, underperforming the broader market. • Factorial Energy shares are sliding. Why is FAC stock dropping? Stellantis Battery Integration The decline followed news that...
Alphabet Shares Are Under Pressure Thursday: What Investors Need To Know

Alphabet Shares Are Under Pressure Thursday: What Investors Need To Know

by Henry Khederian | Jun 11, 2026 | General

Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) shares are trading lower on Thursday as dilution and spending worries around a proposed AI-focused equity raise continue to weigh on sentiment, even with a broadly green tape for risk assets. Here’s what investors need to...
Alphabet Shares Are Under Pressure Thursday: What Investors Need To Know

Alphabet Shares Are Under Pressure Thursday: What Investors Need To Know

by Henry Khederian | Jun 11, 2026 | General

Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) shares are trading lower on Thursday as dilution and spending worries around a proposed AI-focused equity raise continue to weigh on sentiment, even with a broadly green tape for risk assets. Here’s what investors need to...

Vertex Says Pediatric CASGEVY Data Show Consistent Benefits In Rare Blood Disorders

by Vandana Singh | Jun 11, 2026 | General

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported new clinical data showing that CASGEVY (exagamglogene autotemcel) delivered efficacy and safety outcomes in children ages 5 to 11 with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia...

Vertex Says Pediatric CASGEVY Data Show Consistent Benefits In Rare Blood Disorders

by Vandana Singh | Jun 11, 2026 | General

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported new clinical data showing that CASGEVY (exagamglogene autotemcel) delivered efficacy and safety outcomes in children ages 5 to 11 with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia...
« Older Entries
Next Entries »

Recent Posts

  • Why Apple Just Suffered Its Worst Crash In Over A Year
  • Stock Market Today: Dow Jones Inches Up, S&P 500 And Nasdaq Futures Slip As Tech Selloff Gathers Pace— Apple, Beyond Air In Focus
  • Penguin Solutions Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
  • Jamie Dimon Isn’t Leaving Yet, But JPMorgan’s Sweeping Leadership Shake-Up May Have Just Revealed Who Could Replace Him As CEO At America’s Largest Bank
  • Stock Market: Will S&P 500 Open Up Or Down Today?

Recent Comments

    Archives

    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.